Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Choosing between index funds and mutual funds can significantly impact your investment returns. Understand the key factors to make informed decisions.
25,127 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A fresh passively managed strategy centers on established dividend payers to deliver roughly $6,500 a year from a $10...
Lionsgate delivered stronger-than-expected results, and its stock jumped. This article breaks down the key factors be...
Mid-career jobseekers are trimming resumes and curating online profiles as hiring cools and AI filters tighten. The t...
The AI boom isn’t a one-stock story. Here are three well-positioned names beyond Nvidia that could fuel the next rall...
Nvidia sits at the center of a fast-changing tech stack. This article breaks down how the company can reach higher st...
A public clash over strategy and governance wrapped up for now, but 2026 could be a real test for lululemon. This inv...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
A looming base oil shortage threatens routine oil changes as global supply tightens. The ‘imminent’ crisis isn’t pump...
A smaller social media platform is trading under $30 while delivering double-digit revenue growth and robust cash flo...
Ethereum-focused ETFs faced a heavy outflow spell, totaling $708 million over 14 sessions, while XRP and Solana poste...
As TopBuild (BLD) closes 2025, investors look for how revenue, margins, and backlog shape the 2026 outlook. This arti...